therapie-online.de – Date: 29.07.2024
Author: therapie-online.de – Source
Around 2,000 genes in the human body contain errors that can negatively affect health. Dr. Daniel Wallersdorfer, founder of Novogenia, shifted his focus from cloning dinosaurs to human genetics after discovering a genetic defect in himself. His company, a pioneer in Europe, has conducted over 25 million genetic analyses using saliva samples. These tests provide personalised insights into health, diet, and fitness, helping individuals make informed lifestyle choices and minimise the impact of genetic flaws.
Novogenia also offers tailored nutritional supplements and collaborates with medical professionals to identify genetic defects affecting drug metabolism. Although not yet covered by public health insurance, these tests represent the future of preventive healthcare. Wallersdorfer’s vision includes using AI to enhance genetic analysis, potentially enabling early cancer detection and making genetics a tool for better health rather than a predetermined fate.
